Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03701516 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 268
- Enrollment target
NCT03701516 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 268 participants.
The verdict
NCT03701516, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 268 participants
- Enrollment target
Study Summary
This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Interventions
- DEVICE etafilcon A with novel molding process
- DEVICE etafilcon A with current molding process
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2019-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03701516
The ClinicalTrials.gov registry entry for NCT03701516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which etafilcon A with novel molding process is the first listed.
NCT03701516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03701516 about?
NCT03701516 is a clinical study titled "Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2". This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the ...
What is the current status of trial NCT03701516?
This trial is currently completed. It is a NA study. The enrollment target is 268 participants. The study started on 2018-09-24. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03701516?
The interventions under investigation include: etafilcon A with novel molding process (DEVICE), etafilcon A with current molding process (DEVICE).
Who is sponsoring clinical trial NCT03701516?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.